# A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus

> **NCT07073170** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 36 (actual)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** LY3549492
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07073170
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-07-25
- **Primary completion:** 2026-01-27
- **Final completion:** 2026-01-27
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07073170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07073170, "A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07073170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*